Literature DB >> 1468469

Pneumocystis carinii pneumonia associated with adrenocorticotropic hormone treatment for infantile spasms.

R Shamir, B Z Garty.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1468469     DOI: 10.1007/bf01957945

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  6 in total

1.  Pneumocystis carinii pneumonia in infants given adrenocorticotropic hormone for infantile spasms.

Authors:  L M Quittell; M Fisher; C M Foley
Journal:  J Pediatr       Date:  1987-06       Impact factor: 4.406

2.  Fatal Pneumocystis pneumonia from ACTH therapy for infantile spasms.

Authors:  M G Goetting
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

3.  Hypogammaglobulinemia and depressed natural killer cell cytotoxicity in a patient with Pneumocystis carinii infection.

Authors:  R E Staugas; L J Beard; K Simmer; A Ferrante
Journal:  Pediatr Infect Dis J       Date:  1988-10       Impact factor: 2.129

4.  Pneumonia in infants given adrenocorticotropic hormone for infantile spasms.

Authors:  J Lopez Aguado; T Greaves; H T Hutchison; J M McCarty
Journal:  J Pediatr       Date:  1988-03       Impact factor: 4.406

5.  ACTH therapy in infantile spasms: side effects.

Authors:  R Riikonen; M Donner
Journal:  Arch Dis Child       Date:  1980-09       Impact factor: 3.791

Review 6.  Corticosteroid-mediated immunoregulation in man.

Authors:  T R Cupps; A S Fauci
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

  6 in total
  2 in total

1.  Short term outcomes of topiramate monotherapy as a first-line treatment in newly diagnosed West syndrome.

Authors:  Gyu Min Lee; Kyung Suk Lee; Eun Hye Lee; Sajun Chung
Journal:  Korean J Pediatr       Date:  2011-09-30

2.  Topiramate monotherapy in infantile spasm.

Authors:  Young-Se Kwon; Yong-Hoon Jun; Young-Jin Hong; Byong-Kwan Son
Journal:  Yonsei Med J       Date:  2006-08-31       Impact factor: 2.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.